Skip to content

Draft guidelines for the treatment of tuberculosis and HIV published by BHIVA

Differences found between patients stopping HAART for medical or lifestyle reasons

Persistent HIV/hepatitis G co-infection provides significant survival benefit

UN AIDS envoy raises alarm over funding for 3 x 5; 98% shortfall for 2004

Life-threatening allergic reaction after a single dose of abacavir reported

UK to give £3 million to WHO 3 x 5 programme

Surgical options provide good long-term improvement in buffalo hump

NRTI toxicity may be associated with increased cellular activation due to advanced disease

HIV leads to rise in TB incidence in both HIV-positive and HIV-negative SA gold miners

Methamphetamine use by New York gay men risks epidemic of resistant HIV warns opinion piece

HIV transmission after unprotected insertive sex and PEP reported

Atazanavir, once daily protease inhibitor, now available in UK

Women worldwide carrying burden of AIDS, says UN's Annan

Risk factors for non improvement in HAART adherence identified in MACS

Younger injecting drug users and gay men optimistic about HAART likely to have safer sex fatigue

London study finds that gay men answering HIV questionnaire on-line less likely to have been tested

HIV envelope may hold clues to likely treatment response

30% of mother to child HIV infections occur in the womb